General pharmacology of KB-944, a new calcium antagonist.
D000758:Anesthesia; D000818:Animals; D000927:Anticonvulsants; D001341:Autonomic Nervous System / Q000187:drug effects; D052160:Benzothiazoles; D001831:Body Temperature / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002415:Cats; D004064:Digestive System / Q000187:drug effects; D004357:Drug Synergism; D005260:Female; D006168:Guinea Pigs; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009046:Motor Neurons / Q000187:drug effects; D009125:Muscle Relaxants, Central; D009130:Muscle, Smooth / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D012018:Reflex / Q000187:drug effects; D013844:Thiazoles / Q000494:pharmacology*
D000927:Anticonvulsants; D052160:Benzothiazoles; D002121:Calcium Channel Blockers; D009125:Muscle Relaxants, Central; D013844:Thiazoles; C035950:fosfedil